| Mark D Mcgaughey, MD | |
|
5880 University Ave Ste. 102, West Des Moines, IA 50266 | |
| (515) 633-3600 | |
| (515) 288-0840 |
| Full Name | Mark D Mcgaughey |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 45 Years |
| Location | 5880 University Ave Ste. 102, West Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083696744 | NPI | - | NPPES |
| CD4507 | Other | IA | RR MEDICARE GROUP |
| 060020321 | Other | IA | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25191 (Iowa) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | MD-25191 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Dallas County Hospital | Perry, IA | Hospital |
| Grinnell Regional Medical Center | Grinnell, IA | Hospital |
| Broadlawns Medical Center | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Broadlawns Medical Center | 3678466166 | 207 |
| Catholic Health Initiatives-iowa Corp | 5698683142 | 112 |
News Archive
"Long Covid," which affects around 10% of patients, refers to coronavirus disease 2019 (COVID-19) that is still causing symptoms beyond 3 to 4 weeks.
Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.
There is new hope for the treatment of Alzheimer's and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.
A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.
Covalon Technologies Ltd., an advanced medical technologies company, today announced it will be showcasing its advanced medical coating capabilities, including its SilverCoat Antimicrobial Silicone Foley Catheter as well as its recently FDA cleared IV Clear antimicrobial silicone adhesive film dressing from May 19th to May 23rd at the American Urological Association 2012 Annual Meeting in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Catholic Health Initiatives-iowa Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508964883 PECOS PAC ID: 5698683142 Enrollment ID: O20031118000163 |
News Archive
"Long Covid," which affects around 10% of patients, refers to coronavirus disease 2019 (COVID-19) that is still causing symptoms beyond 3 to 4 weeks.
Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.
There is new hope for the treatment of Alzheimer's and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.
A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.
Covalon Technologies Ltd., an advanced medical technologies company, today announced it will be showcasing its advanced medical coating capabilities, including its SilverCoat Antimicrobial Silicone Foley Catheter as well as its recently FDA cleared IV Clear antimicrobial silicone adhesive film dressing from May 19th to May 23rd at the American Urological Association 2012 Annual Meeting in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Broadlawns Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467447508 PECOS PAC ID: 3678466166 Enrollment ID: O20040206000913 |
News Archive
"Long Covid," which affects around 10% of patients, refers to coronavirus disease 2019 (COVID-19) that is still causing symptoms beyond 3 to 4 weeks.
Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.
There is new hope for the treatment of Alzheimer's and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.
A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.
Covalon Technologies Ltd., an advanced medical technologies company, today announced it will be showcasing its advanced medical coating capabilities, including its SilverCoat Antimicrobial Silicone Foley Catheter as well as its recently FDA cleared IV Clear antimicrobial silicone adhesive film dressing from May 19th to May 23rd at the American Urological Association 2012 Annual Meeting in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Dallas County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861416307 PECOS PAC ID: 9931094257 Enrollment ID: O20040217000157 |
News Archive
"Long Covid," which affects around 10% of patients, refers to coronavirus disease 2019 (COVID-19) that is still causing symptoms beyond 3 to 4 weeks.
Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.
There is new hope for the treatment of Alzheimer's and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.
A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.
Covalon Technologies Ltd., an advanced medical technologies company, today announced it will be showcasing its advanced medical coating capabilities, including its SilverCoat Antimicrobial Silicone Foley Catheter as well as its recently FDA cleared IV Clear antimicrobial silicone adhesive film dressing from May 19th to May 23rd at the American Urological Association 2012 Annual Meeting in Atlanta, Georgia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark D Mcgaughey, MD Po Box 9170, Des Moines, IA 50306-9170 Ph: (515) 633-3600 | Mark D Mcgaughey, MD 5880 University Ave Ste. 102, West Des Moines, IA 50266 Ph: (515) 633-3600 |
News Archive
"Long Covid," which affects around 10% of patients, refers to coronavirus disease 2019 (COVID-19) that is still causing symptoms beyond 3 to 4 weeks.
Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.
There is new hope for the treatment of Alzheimer's and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.
A new study provides novel evidence suggesting that suicides are far more likely to occur between midnight and 4 a.m. than during the daytime or evening.
Covalon Technologies Ltd., an advanced medical technologies company, today announced it will be showcasing its advanced medical coating capabilities, including its SilverCoat Antimicrobial Silicone Foley Catheter as well as its recently FDA cleared IV Clear antimicrobial silicone adhesive film dressing from May 19th to May 23rd at the American Urological Association 2012 Annual Meeting in Atlanta, Georgia.
› Verified 6 days ago
Kevin James Cunningham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 151, West Des Moines, IA 50266 Phone: 515-875-9192 Fax: 515-875-9193 | |
Terri L Bunting, A.R.N.P Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 S 51st St, West Des Moines, IA 50265 Phone: 515-440-0304 Fax: 515-440-4623 | |
Jeffrey D Stahl, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1300 37th St, Ste 5, West Des Moines, IA 50266 Phone: 515-225-4051 Fax: 515-225-2265 | |
Richard H Marcus, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5880 University Ave Ste 102, West Des Moines, IA 50266 Phone: 515-633-3600 Fax: 515-288-0840 | |
Mark A Tannenbaum, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5880 University Ave Ste. 102, West Des Moines, IA 50266 Phone: 515-633-3600 Fax: 515-288-0840 | |
Magdi G.h. Ghali, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5880 University Ave Ste. 102, West Des Moines, IA 50266 Phone: 515-633-3600 Fax: 515-288-0840 |